Acetylcholinesterase inhibitors and the risk of osteoporotic fractures: Nested case-control study
Osteoporosis International Jan 07, 2018
Tamimi I, et al. - The link between acetylcholinesterase inhibitors (AChEIs) and the risk of osteoporotic fractures in patients with Alzheimer’s disease (AD), was assessed and quantified in this study using large primary care databases. Findings revealed an association between use and treatment adherence to AChEIs and a decreased risk of osteoporotic fractures in elderly AD patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
